31/07/2025
No Comments
Medical Doctor/Senior Research Scientist/ University Lecturer
Dr. Flavia Matovu Kiweewa
MBChB, MSc. Epidemiology, PhD Public Health
Flavia Matovu Kiweewa
Dr. Flavia Matovu Kiweewa, (MBChB, MSc., Ph.D.) is a Senior Research Scientist/ University Lecturer with over 15 years of experience in conceptualizing, designing, and implementing clinical research studies. She was recently appointed as Director of Research, MU-JHU Research Collaboration. Her research efforts have directly addressed scientific questions related to anti-retroviral based HIV pre-exposure prophylaxis, treatment for women, and hepatitis B.
Insight Into Dr. Flavia's
Experience
Dr. Flavia Kiweewa Matovu is a prominent Ugandan researcher with extensive experience in HIV prevention and treatment. She has contributed significantly to public health through her work on HIV/AIDS clinical trials and the evaluation of prevention strategies, particularly in women and at-risk populations.
YEARS OF EXPERIENCE
0
+
Makerere University College of Health Sciences,
MBChB, Medicine and Surgery
London School of Hygiene & Tropical Medicine
M.Sc. Public Health and Epidemiology
University of Witwatersrand, South Africa
PhD, Public Health
Dr. Flavia Matovu's Portfolio
Dr. Flavia Matovu has contributed to numerous publications, books, guidelines, lectures and key conference presentations. Her widely cited work has significantly impacted global health and public health policies, showcasing her dedication to improving health outcomes worldwide.
Work Experience
Dr. Flavia Matovu Kiweewa is a medical researcher with over 15 years of experience working with global health organizations & Institutions
Education Background
Dr. Flavia Matovu Kiweewa holds advanced degrees and honours in medicine and public health making her one of the most sought after scholars in Uganda
Awards & Recognition
Dr. Flavia Matovu has received numerous awards & recognition for her contributions to the medical field, particularly in HIV prevention & women’s health.
Okulwanyisa Mukenenya mu ggwanga n’Abekitongole ki MU-JHU Care LTD
Ab’ekitongole ki MU-JHU Care LTD Baleese Enkola y’Okujjanjaba Mukenenya
HIV Prevention – Lenacapavir shows 100% efficacy in the purpose one study.
Bone Health in Resource Limited Settings: A Scoping Review
TEMUTYA FFE TUWONYA BULAMU SI KUBUJJAWO -DR. FLAVIA AGUMIZZA BANNANSI KU EDDAGALA ELIGEMA MUKENENYA
EDDAGALA ELIZIYIZA OKUSIGIBWA MUKENENYA LIKOLA ERA TELIRINA BULABE – DR. FLAVIA MATOVU AGUMIZZA
HIV Prevention – Lenacapavir shows 100% efficacy in the purpose one study.
#themightydrive with Dr. Flavia Matovu Kiweewa – Uganda Lead investigator, Lenacapavir for HIV Prevention
EDDAGALA TELIWONYA WABULA LIGEMA KUFUNA KAWUKA KA SIRIMU – DR. FLAVIA AKKATIRIZA KU MPISE EZIYIZA.
Happy International Women’s Day 2024
MUK LECTURER SOARS IN HIV/AIDS RESEARCH Women must look out for areas that benefit society
NEW HIV/AIDS PREVENTION GOVT UNVEILED OPTIONS; EXITING NEWS AHEAD OF 2030 ZERO INFECTION TARGET.
0:00
/
0:00
Radio Simba Interview
Radio News Bulletin
CBS FM News Bulletin
Radio One News Bulletin
Kaboozi FM News Bulletin
UBC News Bulletin
Publications
SELECTED PEER-REVIEWED PUBLICATIONS
Grants
ON-GOING AND COMPLETED GRANTS
Google Scholar
GOOGLE SCHOLAR PROFILE
In The News
11/07/2025
No Comments
Lenacapvir is used for the treatment of HIV, but now we are exploring its role in the prevention of HIV. It has been available in the US and Europe for the past two years - Dr. Flavia Kiweewa ,Makerere University(MU-JHU)#AIDSSymposiumUg pic.twitter.com/i038EfvHqp
— NTV UGANDA (@ntvuganda) December 12, 2024